HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Kos, Quintiles market Advicor and Niaspan

Executive Summary

Quintile Transnational's (CRO) marketing unit Innovex will assist with the US commercialization of Kos Pharmaceuticals' (drug delivery) lead products, Niaspan and Advicor, for the treatment of cholesterol disorders.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Contract
    • Marketing-Licensing

Related Companies